LEXICON PHARMACEUTICALS, INC. (LXRX) Net margin 2017–2025
LEXICON PHARMACEUTICALS, INC. (LXRX) net profit margin by fiscal year — reported net income divided by reported revenue.
-101.1%FY2025 · since FY2017: -774.0% → -101.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -101.1% | +3238.4 pp |
| FY2024 | -3339.5% | +12617.2 pp |
| FY2023 | -15956.7% | — |
| FY2020 | -250.3% | -652.8 pp |
| FY2019 | 402.5% | +856.0 pp |
| FY2018 | -453.5% | +320.5 pp |
| FY2017 | -774.0% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice